Brazil Aesthetic Devices Market Size and Share

Brazil Aesthetic Devices Market (2026 - 2031)
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Brazil Aesthetic Devices Market Analysis by Mordor Intelligence

The Brazil Aesthetic Devices Market size is projected to expand from USD 196.89 million in 2025 and USD 213.51 million in 2026 to USD 345.05 million by 2031, registering a CAGR of 10.08% between 2026 to 2031.

Rapid uptake of minimally and non-invasive procedures, a broadening practitioner base that now includes dentists and general practitioners, and faster ANVISA approvals are accelerating sales of injectables and energy-based platforms. Device demand is also buoyed by a sharp rise in obesity, social-media-driven beauty norms, and private-equity-funded franchise models that lower entry barriers for new clinics. At the same time, elevated SELIC rates, a weaker Brazilian real, and sporadic enforcement against grey-market imports create cost headwinds that favor companies with strong balance sheets and compliant portfolios. Competitive intensity is increasing as South Korean and U.S. manufacturers acquire local distributors or sign exclusive partnerships, signaling that the Brazil aesthetic devices market is becoming a regional launch pad rather than a stand-alone destination.

Key Report Takeaways

  • By device type, non-energy devices dominated with 81.42% share of the Brazil aesthetic devices market in 2025, while energy-based platforms are projected to grow fastest at a 13.43% CAGR through 2031.
  • By application, skin resurfacing and tightening led with 27.45% revenue share in 2025, whereas body contouring and cellulite reduction are forecast to expand at a 14.67% CAGR through 2031.
  • By end user, hospitals and surgical centers captured 39.63% share in 2025, but medical spas and beauty centers are advancing at a 13.42% CAGR over the forecast period.
  • By gender, female patients accounted for 76.24% of total procedures in 2025, yet male treatments are increasing at a 12.77% CAGR through 2031.
  • By age group, individuals aged 35–50 years held 44.13% share in 2025, while the 18–34 cohort is on track to grow at a 13.82% CAGR during 2026–2031.

Note: Market size and forecast figures in this report are generated using Mordor Intelligence’s proprietary estimation framework, updated with the latest available data and insights as of January 2026.

Segment Analysis

By Device Type: Non-Energy Dominates, Energy Platforms Accelerate

Non-energy products represented 81.42% of the Brazil aesthetic devices market in 2025, led by 121 ANVISA-approved hyaluronic-acid fillers that generate repeat sales without large capital outlays. Allergan’s HArmonyCa hybrid and Merz’s Radiesse add collagen-stimulating options that increase procedure frequency among millennials seeking “pre-juvenation.” Implants remain a smaller category but benefit from Silimed’s 12,000 m² factory that supplies domestic clinics and exports to Mercosur neighbors. 

Energy-based systems—lasers, RF, IPL, and HIFU—captured 18.58% in 2025 and will grow at a 13.43% CAGR, pushing the segment’s Brazil aesthetic devices market size above USD 90 million by 2031. Clinical studies show that 1470 nm diode endolaser reduces subcutaneous fat while tightening skin, and BTL’s Emsculpt Neo has logged 55,000 Brazilian treatments that combine RF lipolysis and electromagnetic muscle stimulation. Classys’ acquisition of JL Health provides a direct path to market for the Shurink Universe HIFU system, intensifying competition against Ultherapy and Ultraformer.

Brazil Aesthetic Devices Market: Market Share by Device Type
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
Get Detailed Market Forecasts at the Most Granular Levels
Download PDF

By Application: Body Contouring Momentum Builds

Skin resurfacing and tightening accounted for 27.45% of 2025 revenue, thanks to fractional CO₂ lasers and micro-focused ultrasound that treat photodamage and laxity with minimal downtime. Hair-removal demand remains robust across diode and IPL platforms, anchored by cultural norms favoring smooth skin and falling per-session pricing. 

Body-contouring revenues are poised to rise faster than any other indication, expanding at a 14.67% CAGR as obesity heads toward a 45.5% adult prevalence by 2030. Cryolipolysis, RF, and HIFU technologies appeal to both post-bariatric patients and younger consumers chasing “summer-ready” physiques. The segment could surpass 25% of the overall Brazil aesthetic devices market share by 2031 if forecast adoption rates hold.

By End User: Medical Spa Franchises Scale Quickly

Hospitals and surgical centers retained 39.63% of the Brazil aesthetic devices market size in 2025 due to their capacity to combine surgical and non-surgical offerings under one roof. Yet franchise-backed medical spas are growing 13.42% annually by leveraging group purchasing, standardized protocols, and aggressive social-media marketing. 

XP’s strategic stake in JL Health links equipment sales with Vision One’s hospital network, enabling bundled procurement that squeezes out smaller distributors. Solo dermatology practices struggle to match franchise pricing, especially while SELIC hovers above 13%, raising the cost of financing for new lasers and HIFU platforms.

Brazil Aesthetic Devices Market: Market Share by End User
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

Get Detailed Market Forecasts at the Most Granular Levels
Download PDF

By Gender: Male Uptake Narrows the Gap

Women still represented 76.24% of procedure volume in 2025, sustained by high filler usage and female-specific indications such as intimate rejuvenation. 

Male demand is expanding at 12.77% CAGR, with liposuction volumes up 46% over five years and rising interest in botulinum toxin, RF skin tightening, and Fotona laser facial harmonization. Clinics now market “Bro-Tox” and body-sculpt packages expressly to male influencers and athletes, eroding the once-wide gender gap.

By Age Group: Digital Natives Spur Preventive Care

Patients aged 35-50 held 44.13% share in 2025, anchored by corrective treatments such as deep-plane fillers and fractional resurfacing. 

The 18-34 cohort is accelerating at a 13.82% CAGR, normalizing quarterly micro-botox and biostimulator boosters as routine skin maintenance. Academic evidence ties Instagram exposure to elevated procedural interest, turning first-time patients into long-term subscribers who drive repeat device utilization.

Brazil Aesthetic Devices Market: Market Share by Age Group
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

Get Detailed Market Forecasts at the Most Granular Levels
Download PDF

Geography Analysis

Brazil’s Southeast corridor—São Paulo, Rio de Janeiro, and Minas Gerais—generates more than 60% of national revenue and attracts the earliest launches of new lasers, fillers, and hybrid injectables. São Paulo alone logged 42 healthcare-sector M&A deals worth BRL 7.69 billion in 2021, confirming its status as the commercial backbone for the Brazil aesthetic devices market. Enforcement under ANVISA’s “Safe Aesthetics Operation” is most vigorous here, giving compliant clinics a marketing edge. 

The South—Paraná, Santa Catarina, and Rio Grande do Sul—shows high male procedure penetration and rapid uptake of franchise medical-spa formats. Santa Catarina clinics report steady demand for facial harmonization among men in their early thirties, reflecting regional cultural openness to aesthetic intervention. 

Growth frontiers include the Northeast and Central-West, where improving household incomes intersect with rising obesity and aging metrics. Nonetheless, sparse dermatologist density and limited capital access slow technology adoption relative to the coast. The North remains the most underserved; logistical obstacles and fewer accredited practitioners curtail supply, though local manufacturers such as Silimed leverage lower operating costs to ship implants region-wide.

Competitive Landscape

The Brazil aesthetic devices market hosts a mix of multinationals includes AbbVie/Allergan, Galderma, Merz, BTL, Candela, Cutera, and Lumenis and local champions such as JL Health, HTM Eletrônica, Ibramed, and Silimed. Bain-Capital-backed Classys now owns 77.5% of JL Health, turning the distributor into a forward operating base for the Shurink Universe HIFU system. XP’s BRL 225 million minority stake injects capital to push JL Health into gynecology, ophthalmology, and orthopedics while bundling device sales with Vision One hospital purchases . 

Technology pipelines focus on hybrid and combination platforms: Allergan’s HArmonyCa mixes HA with CaHa microspheres; BTL’s Emsculpt Neo pairs RF lipolysis with magnetic muscle stimulation. Korean innovators Hugel and Classys differentiate through competitive pricing and robust educator networks, evidenced by Hugel’s partnership with Derma Dream to launch Letybo toxin across elite clinics in Rio and São Paulo. 

ANVISA’s rigorous but transparent regulatory process, especially under RDC 751/2022, advantages firms with deep clinical dossiers. Grey-market crackdowns further tilt share toward companies that can document sterility, traceability, and post-market surveillance, setting up consolidation waves that favor players with diversified product portfolios and strong compliance teams.

Brazil Aesthetic Devices Industry Leaders

  1. Cutera Inc.

  2. Galderma

  3. AbbVie (Allergan Aesthetics)

  4. Candela Corporation

  5. Lumenis Be Ltd

  6. *Disclaimer: Major Players sorted in no particular order
Brazil Aesthetic Devices Market Concentration
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
Need More Details on Market Players and Competitors?
Download PDF

Recent Industry Developments

  • January 2026: The Aesthetic Society, The Aesthetic Foundation, and The American-Brazilian Aesthetic Meeting unveiled a purpose-driven partnership centered on patient safety and charitable outreach.
  • January 2026: PharmaResearch signed an exclusive deal with Derma Dream to supply Rejuran polynucleotide injectables in preparation for Brazilian market entry.
  • September 2025: Hugel accelerated Brazilian expansion through a distribution agreement with Derma Dream for its Letybo botulinum toxin product.

Table of Contents for Brazil Aesthetic Devices Industry Report

1. Introduction

  • 1.1 Study Assumptions & Market Definition
  • 1.2 Scope of the Study

2. Research Methodology

3. Executive Summary

4. Market Landscape

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rapid Uptake of Minimally- & Non-Invasive Procedures
    • 4.2.2 Growing Social-Media-Driven Beauty Consciousness
    • 4.2.3 Ageing & Obesity Trends Driving Body-Contouring Demand
    • 4.2.4 Device Miniaturization Spurring Home-Use Segment
    • 4.2.5 ANVISA Fast-Track Approvals (RDC 751/2022)
    • 4.2.6 Venture-Capital Inflow to Local OEMs
  • 4.3 Market Restraints
    • 4.3.1 High Cap-Ex for Advanced Platforms
    • 4.3.2 Practitioner-Training Gaps & Safety Incidents
    • 4.3.3 Economic Volatility Hitting Discretionary Spend
    • 4.3.4 Grey-Market Device Imports
  • 4.4 Value / Supply-Chain Analysis
  • 4.5 Regulatory Landscape
  • 4.6 Technological Outlook
  • 4.7 Porter's Five Forces Analysis
    • 4.7.1 Threat of New Entrants
    • 4.7.2 Bargaining Power of Suppliers
    • 4.7.3 Bargaining Power of Buyers
    • 4.7.4 Threat of Substitutes
    • 4.7.5 Intensity of Competitive Rivalry

5. Market Size & Growth Forecasts (Value in USD)

  • 5.1 By Device Type
    • 5.1.1 Energy-based Devices
    • 5.1.1.1 Laser-based
    • 5.1.1.2 Radiofrequency
    • 5.1.1.3 IPL & Light-based
    • 5.1.1.4 Ultrasound / HIFU
    • 5.1.2 Non-energy Devices
    • 5.1.2.1 Dermal Fillers & Injectables
    • 5.1.2.2 Implants
    • 5.1.2.3 Microdermabrasion & Dermarollers
  • 5.2 By Application
    • 5.2.1 Skin Resurfacing & Tightening
    • 5.2.2 Hair Removal
    • 5.2.3 Body Contouring & Cellulite Reduction
    • 5.2.4 Facial Aesthetic Procedures
    • 5.2.5 Pigmented & Vascular Lesion Treatment
    • 5.2.6 Others
  • 5.3 By End User
    • 5.3.1 Dermatology and Asthetic Clinics
    • 5.3.2 Hospitals & Surgical Centers
    • 5.3.3 Medical Spas & Beauty Centers
    • 5.3.4 Home-use
  • 5.4 By Gender
    • 5.4.1 Female
    • 5.4.2 Male
  • 5.5 By Age Group
    • 5.5.1 18-34 Years
    • 5.5.2 35-50 Years
    • 5.5.3 Above 50 Years

6. Competitive Landscape

  • 6.1 Market Concentration
  • 6.2 Market Share Analysis
  • 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products and Services, and Recent Developments)
    • 6.3.1 AbbVie (Allergan Aesthetics)
    • 6.3.2 BTL Aesthetics
    • 6.3.3 Candela Corporation
    • 6.3.4 Classys
    • 6.3.5 Cutera Inc.
    • 6.3.6 Fotona
    • 6.3.7 Galderma
    • 6.3.8 Hologic
    • 6.3.9 HTM Eletrônica
    • 6.3.10 Hugel
    • 6.3.11 Ibramed Tonederm
    • 6.3.12 Lumenis Be Ltd
    • 6.3.13 Merz Pharma
    • 6.3.14 Sciton Inc.
    • 6.3.15 Silimed
    • 6.3.16 Sisram
    • 6.3.17 Syneron Medical
    • 6.3.18 Venus Concept
    • 6.3.19 VYDENCE Medical

7. Market Opportunities & Future Outlook

  • 7.1 White-space & Unmet-need Assessment
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Brazil Aesthetic Devices Market Report Scope

As per the scope of the report, Aesthetic devices are tools used for non-surgical or minimally invasive cosmetic procedures to improve appearance through technologies like lasers, radiofrequency, ultrasound, and light.

The Brazil Aesthetic Devices Market Report is segmented by Device Type, Application, End User, Gender, and Age Group. By Device Type, the market is segmented into Energy-based Devices (Laser-based, Radiofrequency, IPL & Light-based, Ultrasound/HIFU) and Non-energy Devices (Dermal Fillers & Injectables, Implants, Microdermabrasion & Dermarollers). By Application, the market is segmented into Skin Resurfacing & Tightening, Hair Removal, Body Contouring & Cellulite Reduction, Facial Aesthetic Procedures, Pigmented & Vascular Lesion Treatment, and Others. By End User, the market is segmented into Dermatology and Aesthetic Clinics, Hospitals & Surgical Centers, Medical Spas & Beauty Centers, and Home‑use. By Gender, the market is segmented into Female and Male. By Age Group, the market is segmented into 18–34 Years, 35–50 Years, and Above 50 Years. Market Forecasts are Provided in Terms of Value (USD).

By Device Type
Energy-based DevicesLaser-based
Radiofrequency
IPL & Light-based
Ultrasound / HIFU
Non-energy DevicesDermal Fillers & Injectables
Implants
Microdermabrasion & Dermarollers
By Application
Skin Resurfacing & Tightening
Hair Removal
Body Contouring & Cellulite Reduction
Facial Aesthetic Procedures
Pigmented & Vascular Lesion Treatment
Others
By End User
Dermatology and Asthetic Clinics
Hospitals & Surgical Centers
Medical Spas & Beauty Centers
Home-use
By Gender
Female
Male
By Age Group
18-34 Years
35-50 Years
Above 50 Years
By Device TypeEnergy-based DevicesLaser-based
Radiofrequency
IPL & Light-based
Ultrasound / HIFU
Non-energy DevicesDermal Fillers & Injectables
Implants
Microdermabrasion & Dermarollers
By ApplicationSkin Resurfacing & Tightening
Hair Removal
Body Contouring & Cellulite Reduction
Facial Aesthetic Procedures
Pigmented & Vascular Lesion Treatment
Others
By End UserDermatology and Asthetic Clinics
Hospitals & Surgical Centers
Medical Spas & Beauty Centers
Home-use
By GenderFemale
Male
By Age Group18-34 Years
35-50 Years
Above 50 Years
Need A Different Region or Segment?
Customize Now

Key Questions Answered in the Report

How large is the Brazil aesthetic devices market in 2026?

It was valued at USD 213.51 million in 2026 and is projected to reach USD 345.05 million by 2031 at a 10.08% CAGR.

Which segment is growing fastest in Brazilian body-contouring treatments?

Body-contouring and cellulite-reduction devices are forecast to expand at 14.67% CAGR through 2031, outpacing all other applications.

Why are dentists important buyers of aesthetic devices in Brazil?

Dentists perform 43% of clinic-based procedures and 87% of total injectables, widening the practitioner base and accelerating equipment adoption.

How is macroeconomic volatility affecting device sales?

High SELIC rates, a weaker real, and slower GDP growth are raising financing costs and suppressing discretionary spending, cutting 2.0 percentage points from near-term CAGR.

What regulatory change is most influential for new device launches?

ANVISA’s RDC 751/2022 fast-track pathway shortens approval times by referencing FDA and CE dossiers, adding 1.5 percentage points to market CAGR in the short term.

Which companies recently made strategic moves in Brazil?

Classys bought 77.5% of JL Health to launch Shurink Universe HIFU, while Hugel partnered with Derma Dream to roll out Letybo botulinum toxin.

Page last updated on:

Brazil Aesthetic Devices Market Report Snapshots